China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a report issued on Monday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of CPHI opened at $0.32 on Monday. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19. China Pharma has a one year low of $0.27 and a one year high of $2.18. The business has a fifty day moving average of $0.35 and a 200 day moving average of $0.45.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.